Atomo Diagnostics Limited (AT1.AX)
AUD 0.02
(-5.0%)
AUD 0.02
(-5.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 11.37 Million AUD | -30.93% |
| 2023 | 16.47 Million AUD | -38.12% |
| 2022 | 26.62 Million AUD | -17.42% |
| 2021 | 32.23 Million AUD | -10.7% |
| 2020 | 36.1 Million AUD | 496.68% |
| 2019 | 6.05 Million AUD | -21.99% |
| 2018 | 7.75 Million AUD | -34.65% |
| 2017 | 11.86 Million AUD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 14.93 Million AUD | -9.36% |
| 2024 FY | 11.37 Million AUD | -30.93% |
| 2024 Q4 | 11.37 Million AUD | -23.8% |
| 2023 Q2 | 20.36 Million AUD | -23.49% |
| 2023 Q4 | 16.47 Million AUD | -19.13% |
| 2023 FY | 16.47 Million AUD | -38.12% |
| 2022 Q4 | 26.62 Million AUD | -11.35% |
| 2022 FY | 26.62 Million AUD | -17.42% |
| 2022 Q2 | 30.02 Million AUD | -6.85% |
| 2021 Q4 | 32.23 Million AUD | -7.95% |
| 2021 Q2 | 35.02 Million AUD | -2.98% |
| 2021 FY | 32.23 Million AUD | -10.7% |
| 2020 FY | 36.1 Million AUD | 496.68% |
| 2020 Q4 | 36.1 Million AUD | 105.96% |
| 2020 Q2 | 17.52 Million AUD | 189.71% |
| 2019 Q4 | 6.05 Million AUD | 0.0% |
| 2019 FY | 6.05 Million AUD | -21.99% |
| 2018 FY | 7.75 Million AUD | -34.65% |
| 2017 FY | 11.86 Million AUD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| 4DMedical Limited | 120.01 Million AUD | 90.519% |
| Adherium Limited | 9.88 Million AUD | -15.089% |
| Aroa Biosurgery Limited | 101.82 Million AUD | 88.825% |
| Anteris Technologies Ltd | 45.7 Million AUD | 75.101% |
| Control Bionics Limited | 9.02 Million AUD | -26.051% |
| CardieX Limited | 12.64 Million AUD | 10.046% |
| Compumedics Limited | 40.35 Million AUD | 71.805% |
| Cochlear Limited | 2.74 Billion AUD | 99.585% |
| CleanSpace Holdings Limited | 26.05 Million AUD | 56.321% |
| Cyclopharm Limited | 45.91 Million AUD | 75.217% |
| EMVision Medical Devices Ltd | 23.97 Million AUD | 52.531% |
| Nova Eye Medical Limited | 29.88 Million AUD | 61.92% |
| HeraMED Limited | 2.95 Million AUD | -285.456% |
| Imricor Medical Systems, Inc. | 12.17 Million AUD | 6.546% |
| ImpediMed Limited | 46.98 Million AUD | 75.782% |
| InhaleRx Limited | 1.57 Million AUD | -621.614% |
| LBT Innovations Limited | 7.93 Million AUD | -43.475% |
| Micro-X Limited | 26.89 Million AUD | 57.691% |
| Neurotech International Limited | 12.21 Million AUD | 6.832% |
| OncoSil Medical Limited | 6.71 Million AUD | -69.371% |
| PolyNovo Limited | 109.16 Million AUD | 89.577% |
| Respiri Limited | 6.19 Million AUD | -83.802% |
| SomnoMed Limited | 69.8 Million AUD | 83.699% |
| Universal Biosensors, Inc. | 30.12 Million AUD | 62.222% |
| Uscom Limited | 5.13 Million AUD | -121.613% |
| Visioneering Technologies, Inc. | 11.2 Million AUD | -1.549% |